SCHEMBL20579760

SCHEMBL20579760

Cc1nc2ccccn2c1C(=O)OCC(F)(F)F

nearest known ligand 0.74

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 1/20 0.74
▸ ALDH1A1 P00352 4/20 0.66
▸ RXFP1 Q9HBX9 1/20 0.66
▸ KMT2A Q03164 2/20 0.58
▸ KDM4E B2RXH2 3/20 0.56
▸ GAA P10253 1/20 0.56
▸ NPSR1 Q6W5P4 1/20 0.54
▸ HSD17B10 Q99714 1/20 0.54
▸ SMN1; SMN2 Q16637 4/20 0.54
▸ CYP1A2 P05177 1/20 0.54
▸ CYP2C9 P11712 1/20 0.54
▸ CYP2C19 P33261 1/20 0.54
▸ HTT P42858 3/20 0.51
▸ LMNA P02545 1/20 0.48
▸ PKM P14618 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2829842 0.85 MAPK1 (1.00) MAPK1ALDH1A1RXFP1KMT2AKDM4E
SCHEMBL20580266 0.83 CYP1A2 (0.57) MAPK1ALDH1A1RXFP1KMT2AKDM4E
SCHEMBL20579832 0.83 CYP1A2 (0.66) MAPK1ALDH1A1RXFP1KMT2AKDM4E
SCHEMBL20579758 0.82 CYP1A2 (0.72) MAPK1ALDH1A1RXFP1KMT2AKDM4E
SCHEMBL20579820 0.81 CYP1A2 (0.62) MAPK1ALDH1A1RXFP1KMT2AKDM4E
SCHEMBL18610805 0.81 MAPK1 (0.76) MAPK1ALDH1A1RXFP1KMT2AKDM4E
SCHEMBL20579778 0.80 MAPK1 (0.51) MAPK1ALDH1A1RXFP1KMT2AKDM4E
SCHEMBL15742282 0.80 MAPK1 (0.70) MAPK1ALDH1A1RXFP1KMT2AKDM4E
SCHEMBL20579799 0.79 SMN1; SMN2 (0.60) MAPK1ALDH1A1KMT2AKDM4ENPSR1
SCHEMBL21097067 0.79 SMN1; SMN2 (0.60) MAPK1ALDH1A1RXFP1KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10323033-B2 Imidazo[1,2-A]pyridine-3-carboxylate derivative and preparation method thereof KNU-INDUSTRY COOPERATION FOUNDATION (KR) 2019-06-18 — — US disclosed
US-10323033-B2 Imidazo[1,2-A]pyridine-3-carboxylate derivative and preparation method thereof KNU-INDUSTRY COOPERATION FOUNDATION (KR) 2019-06-18 — — US disclosed
US-20180354948-A1 IMIDAZO[1,2-A]PYRIDINE-3-CARBOXYLATE DERIVATIVE AND PREPARATION METHOD THEREOF KNU-INDUSTRY COOPERATION FOUNDATION (KR) 2018-12-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180354948-A1 IMIDAZO[1,2-A]PYRIDINE-3-CARBOXYLATE DERIVATIVE AND PREPARATION METHOD THEREOF AZI2, AOC3, AOC2 MAPK1 1499/4885ALDH1A1 68/4885RXFP1 3971/4885
US-10323033-B2 Imidazo[1,2-A]pyridine-3-carboxylate derivative and preparation method thereof AZI2, AOC3, AOC2 MAPK1 1499/4885ALDH1A1 68/4885RXFP1 3971/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback